Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 2, 2000, Pages 147-154

  Denis Mize, Kimberly S ^a   Price, Brian M ^a   Baker, Neil R ^a,b   Galloway, Darrell R ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

DNA immunization; DNA vaccine; Exotoxin A; Pseudomonas aeruginosa

Indexed keywords

DNA VACCINE; MUTANT PROTEIN; NEUTRALIZING ANTIBODY; PSEUDOMONAS EXOTOXIN; PSEUDOMONAS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG EFFICACY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; IMMUNOPROPHYLAXIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; TH1 CELL;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; EXOTOXINS; FEMALE; HUMANS; MALE; MELANOMA; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PLASMIDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TH1 CELLS; TRANSFECTION; TUMOR CELLS, CULTURED; VACCINATION; VACCINES, DNA; VIRULENCE FACTORS;

EID: 0033955336     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00182-0     Document Type: Article

References (32)

1. CDC (1998) Hospital Infections Program. www.cdc.gov/ncidod/hip/icw.htm.
2. Horan T.C., White J.W., Jarvis W.R., Emori G., Culver D.H., Munn V.P., Thornsberry C., Olson D.R., Hughes J.M. Nosocomial infection surveillance. MMWR. 35:1986;17-29.
3. Holder I.A. Pseudomonas immunotherapy. Serodiagn. Immunother. 2:1988;7-16.
4. Tang D.C., Devit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature (Lond.). 356:1992;152-154.
5. Waine G.J., McManus D.P. Nucleic acids: vaccines of the future. Parasitol. Today. 11:1993;113-116.
6. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
7. Robinson, H.L., Ginsberg, H.S., Davis, H.L., Johnston, S.A. and Liu, M.A. (1997) The Scientific Future of DNA for Immunization. American Academy of Microbiology.
8. Anderson R., Gao X.M., Papakonstantinopoulou A., Roberts M., Dougan G. Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin. Infect. Immun. 64:1996;3168-3173.
9. Barry M.A., Lai W.C., Johnston S.A. Protection against Mycoplasma infection using expression-library immunization. Nature. 377:1995;632-635.
10. Hwang J., FitzGerald D.J., Adhya S., Pastan I. Functional domains of Pseudomonas aeruginosa exotoxin A identified by deletion analysis of the gene expressed in E. coli. Cell. 48:1987;129-136.
11. Allured V.S., Collier R.J., Carroll S.F., McKay D.B. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Å resolution. Proc. Natl. Acad. Sci. USA. 83:1986;1320-1324.
12. Kounnas M.Z., Morris R.E., Thompson M.R., FitzGerald D.J., Strickland D.K., Saelinger C.B. The α2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem. 267:1992;12420.
13. Inocencio N.M., Moehring J.M., Moehring T.J. Furin activates Pseudomonas exotoxin A by specific cleavage in vivo and in vitro. J. Biol. Chem. 269:1994;31831.
14. 280 generates the enzymatically active fragment which translocates to the cytosol. J. Biol. Chem. 267:1992;25396-25401.
15. Cross A.S., Sadoff J.C., Iglewski B.H., Sokol P.A. Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans. J. Infect. Dis. 142:1980;538-546.
16. Pavlovskis O.R., Pollack M., Callahan L.T., Iglewski B.H. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. Infect. Immun. 18:1977;596-602.
17. Pollack M., Young L.S. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the outset of Pseudomonas aeruginosa septicemia in man. J. Clin. Invest. 63:1979;276-286.
18. Leppla S. Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa. Infect. Immun. 14:1976;1077-1086.
19. Wozniak D.J., Han X.Y., Galloway D.R. Construction and use of a nontoxigenic strain of Pseudomonas aeruginosa for the production of recombinant exotoxin A. Appl. Environ. Microbiol. 61:1995;1739-1744.
20. Luke C.J., Carner K., Liang X., Barbour A.G. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 175:1997;91-97.
21. Harlow, E. and Lane, D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
22. Voller, A., Bidwell, D.E. and Bartlett, A. (1979) The Enzyme-linked Immunosorbent Assay. Dynatech Laboratories, Alexandria, VA.
23. Iglewski B.H., Sadoff J.C. Toxin inhibitors of protein synthesis: production, purification and assay of Pseudomonas aeruginosa toxin A. Methods Enzymol. 60:1979;780-793.
24. Holt P.S., Misfeldt M.L. Induction of an immune response in athymic nude mice to thymus-dependent antigens by Pseudomonas aeruginosa exotoxin A. Cell. Immunol. 95:1985;265-275.
25. Davies J. Bacteria on the rampage. Nature. 383:1996;219-220.
26. Wels W., Baldrich M., Chakraborty T., Gross R., Goebel W. Expression of bacterial cytotoxin genes in mammalian target cells. Mol. Microbiol. 6:1992;2651-2659.
27. Whalen, R. (1996) DNA vaccines, cyberspace and self-help programs. www.genweb.com/Dnavax/dnavax.html.
28. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA. 91:1994;9866-9870.
29. Petmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119-6125.
30. Ulmer, J.B., Donnelly, J.J., Deck, R.R., DeWitt, C.M. and Liu, M.A. (1995) Immunization against viral proteins with naked DNA, pp. 117-125. DNA Vaccines: a New Era in Vaccinology, The New York Academy of Sciences.
31. Whalen R. DNA vaccines for emerging infectious diseases: what if? Emerg. Infect. Dis. 2:1996;168-175.
32. Whalen R.G., Davis H.L. DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen. Clin. Immun. Immunopathol. 75:1995;1-12.